Effectiveness of antral in correction of metabolic disorders in patients with non-alcoholic steatohepatitis and chronic obstructive pulmonary disease

Abstract

The steady increase in the incidence of comorbidity of chronic obstructive pulmonary disease (COPD) and non-alcoholic steatohepatitis (NASH) against the background of obesity in people of working age in Ukraine and the world stipulates the need for investigation of the mechanisms of interconnection and the search for new factors of the pathogenesis of progression of this comorbid pathology.